TDX BENZODIAZEPINES SERUM— 510(k) K883730

Substantially Equivalent

Abbott Laboratories

FDA 510(k) clearance K883730 for TDX BENZODIAZEPINES SERUM, Substantially Equivalent on 1988-11-29. Applicant: Abbott Laboratories.

Clearance details

Applicant: Abbott Laboratories
Product code: Code JXM
Advisory panel: Clinical Toxicology
Date received: 1988-08-31
Decision date: 1988-11-29
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Abbott Park, IL, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.